{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:07:12Z","timestamp":1760144832888,"version":"build-2065373602"},"reference-count":12,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T00:00:00Z","timestamp":1716595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Pro- and anticoagulant factors are core components of hemostasis [...]<\/jats:p>","DOI":"10.3390\/ijms25115741","type":"journal-article","created":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T10:12:27Z","timestamp":1716804747000},"page":"5741","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Special Issue \u201cGenetic, Functional and Therapeutic Aspects of Procoagulant and Anticoagulant Factors\u201d"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1279-2557","authenticated-orcid":false,"given":"Tami","family":"Livnat","sequence":"first","affiliation":[{"name":"The Amalia Biron Research Institute of Thrombosis and Hemostasis, Faculty of Medical and Health Sciences, Tel-Aviv University and the National Hemophilia Center Sheba Medical Center, Tel-Hashomer 52621, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rima","family":"Dardik","sequence":"additional","affiliation":[{"name":"The Amalia Biron Research Institute of Thrombosis and Hemostasis, Faculty of Medical and Health Sciences, Tel-Aviv University and the National Hemophilia Center Sheba Medical Center, Tel-Hashomer 52621, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,5,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/BF02321003","article-title":"Die Chemie der Blutgerinnung","volume":"4","author":"Morawitz","year":"1905","journal-title":"Ergeb. Physiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJMra0801082","article-title":"Mechanisms of Thrombus Formation","volume":"359","author":"Furie","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1126\/science.145.3638.1310","article-title":"Waterfall Sequence for Intrinsic Blood Clotting","volume":"145","author":"Davie","year":"1964","journal-title":"Science"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1055\/s-0037-1615947","article-title":"A Cell-Based Model of Hemostasis","volume":"85","author":"Hoffman","year":"2001","journal-title":"Thromb. Haemost."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1126\/science.3029867","article-title":"The Regulation of Natural Anticoagulant Pathways","volume":"235","author":"Esmon","year":"1987","journal-title":"Science"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1365-2141.2008.07323.x","article-title":"Virchow and His Triad: A Question of Attribution","volume":"143","author":"Bagot","year":"2008","journal-title":"Br. J. Haematol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.it.2004.08.003","article-title":"Interactions Between the Innate Immune and Blood Coagulation Systems","volume":"25","author":"Esmon","year":"2004","journal-title":"Trends Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Hisada, Y., and Mackman, N. (2021). Tissue Factor and Extracellular Vesicles: Activation of Coagulation and Impact on Survival in Cancer. Cancers, 13.","DOI":"10.3390\/cancers13153839"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3324\/haematol.2019.232132","article-title":"Hemophilia Therapy: The future has begun","volume":"105","author":"Mannucci","year":"2020","journal-title":"Haematologica"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1182\/hematology.2022000388","article-title":"Gene Therapy for Hemophilia","volume":"2022","author":"Nathwani","year":"2022","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Sarafanov, A.G. (2023). Plasma Clearance of Coagulation Factor VIII and Extension of Its Half-Life for the Therapy of Hemophilia A: A Critical Review of the Current State of Research and Practice. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24108584"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Dardik, R., Janczar, S., Lalezari, S., Avishai, E., Levy-Mendelovich, S., Barg, A.A., Martinowitz, U., Babol-Pokora, K., Mlynarski, W., and Kenet, G. (2023). Four Decades of Carrier Detection and Prenatal Diagnosis in Hemophilia A: Historical Overview, State of the Art and Future Directions. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241411846"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/11\/5741\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:48:32Z","timestamp":1760107712000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/11\/5741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,25]]},"references-count":12,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["ijms25115741"],"URL":"https:\/\/doi.org\/10.3390\/ijms25115741","relation":{},"ISSN":["1422-0067"],"issn-type":[{"type":"electronic","value":"1422-0067"}],"subject":[],"published":{"date-parts":[[2024,5,25]]}}}